Cancer Research UK Plans Large PGx Project | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cancer Research UK is plotting a multi-pronged pilot project that it says will be a large step towards personalizing cancer care and making genetic testing "routine practice," the nonprofit group said yesterday in a blog posting by its Director of Stratified Medicine, James Peach.

The organization intends to build a partnership between the research community, the National Health Service, drug and diagnostics companies, and the government.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.